Literature DB >> 20551897

Use of cidofovir for the treatment of HIV-negative human herpes virus-8-associated primary effusion lymphoma.

Tamara K Moyo1, Kristy L Richards, Blossom Damania.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20551897      PMCID： PMC3072025     

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  24 in total

1.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

Authors:  Adam Grundhoff; Don Ganem
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

2.  Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir.

Authors:  M Luppi; R Trovato; P Barozzi; D Vallisa; G Rossi; A Re; L Ravazzini; L Potenza; G Riva; M Morselli; G Longo; L Cavanna; R Roncaglia; G Torelli
Journal:  Leukemia       Date:  2005-03       Impact factor: 11.528

3.  Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.

Authors:  J P Lalezari; R J Stagg; B D Kuppermann; G N Holland; F Kramer; D V Ives; M Youle; M R Robinson; W L Drew; H S Jaffe
Journal:  Ann Intern Med       Date:  1997-02-15       Impact factor: 25.391

4.  In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.

Authors:  M M Medveczky; E Horvath; T Lund; P G Medveczky
Journal:  AIDS       Date:  1997-09       Impact factor: 4.177

5.  The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions.

Authors:  K V Komanduri; J A Luce; M S McGrath; B G Herndier; V L Ng
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-11-01

6.  Antiviral drug susceptibility of human herpesvirus 8.

Authors:  J Neyts; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

7.  Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS.

Authors:  J P Lalezari; G N Holland; F Kramer; G F McKinley; C A Kemper; D V Ives; R Nelson; W D Hardy; B D Kuppermann; D W Northfelt; M Youle; M Johnson; R A Lewis; D V Weinberg; G L Simon; R A Wolitz; A E Ruby; R J Stagg; H S Jaffe
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-04-01

8.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

Review 9.  Cidofovir.

Authors:  A P Lea; H M Bryson
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

10.  High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy.

Authors:  Alessandro Re; Chiara Cattaneo; Mariagrazia Michieli; Salvatore Casari; Michele Spina; Maurizio Rupolo; Bernardino Allione; Annamaria Nosari; Clara Schiantarelli; Mariagrazia Vigano; Immacolata Izzi; Piero Ferremi; Arnalda Lanfranchi; Mauro Mazzuccato; Gianpiero Carosi; Umberto Tirelli; Giuseppe Rossi; Maurizio Mazzuccato
Journal:  J Clin Oncol       Date:  2003-10-27       Impact factor: 44.544
View more
  6 in total

1.  Antitumor action of temozolomide, ritonavir and aprepitant against human glioma cells.

Authors:  Richard E Kast; Susana Ramiro; Sandra Lladó; Salvador Toro; Rafael Coveñas; Miguel Muñoz
Journal:  J Neurooncol       Date:  2015-11-24       Impact factor: 4.130

2.  Human Immunodeficiency Virus (HIV)-Negative and Human Herpes Virus-8 (HHV-8)-Positive Primary Effusion Lymphoma: A Case Report and Review of the Literature.

Authors:  Sonay Güven Karataş; Reyhan Bayrak; Ozlem Sahin Balçık; Kadir Serkan Yalçın; Esra Atıcı; Umit Akyıldız; Ali Koşar
Journal:  Turk J Haematol       Date:  2013-03-05       Impact factor: 1.831

Review 3.  KSHV targeted therapy: an update on inhibitors of viral lytic replication.

Authors:  Natacha Coen; Sophie Duraffour; Robert Snoeck; Graciela Andrei
Journal:  Viruses       Date:  2014-11-24       Impact factor: 5.048

Review 4.  Viral Oncology: Molecular Biology and Pathogenesis.

Authors:  Uyen Ngoc Mui; Christopher T Haley; Stephen K Tyring
Journal:  J Clin Med       Date:  2017-11-29       Impact factor: 4.241

5.  [Primary effusion lymphoma in a HIV-negative patient: case report and literatures review].

Authors:  Y F Song; H Liu; J F Bai; H X Ke; J T Li; T Wang; Y Z Yang; J J Yin; R Feng
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-08-14

Review 6.  Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.

Authors:  Arun George Paul; Bala Chandran; Neelam Sharma-Walia
Journal:  Transl Res       Date:  2013-04-06       Impact factor: 7.012
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.